Topic

Lisa Henderson is the group editorial director of 

 and can be reached at lhenderson@mjhlifesciences.com.

Articles

Ahead of ASCO and BIO, Michael Bailey CEO of AVEO Oncology, discusses the company becoming a LG Chem subsidiary and the future for drug development in the combined entity.

Acquisition and Investment Spur AVEO Oncology to New Heights

, an MJH Life Sciences sister publication. 

How the pivot to corporate development became a natural fit for the once-destined scientist. (The story of Natasha A. Hernday, chief business officer of Seagen and a 2023 Emerging Pharma Leader.)

From Science to Strategy | 2023 Emerging Pharma Leader

Miranda Schmalfuhs is the associate group social media editor of 

Pharmaceutical Executive, Pharmaceutical Commerce

 and can be reached at mschmalfuhs@mjhlifesciences.com.

Driving commercial growth and patient access and empowerment in women’s health. (The story of Simon Holland, vice president, women's health commercial lead, for Organon and a 2023 Emerging Pharma Leader.)

Committed to the Cause | 2023 Emerging Pharma Leader

 and can be reached at mhollan@mjhlifesciences.com.

The recipe for cross-functional collaboration in drug development. (The story of Justin To, chief operating officer, skeletal dysplasias and gene therapy, for Bridge Bio and a 2023 Emerging Pharma Leader.)

A Knack for Problem-Solving | 2023 Emerging Pharma Leader

 and can be reached at fpollaro@mjhlifesciences.com.

Chronicling one leader’s call to duty in dermatology. (The story of Frank Watanabe, president and CEO of Arcutis Biotherapeutics and a 2023 Emerging Pharma Leader.)

Mission-Fueled Mindset | 2023 Emerging Pharma Leader

 and can be reached at mrivers@mjhlifesciences.com.

Scientist-turned-entrepreneur steers efforts to transform approaches in tissue regeneration. (The story of Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics and a 2023 Emerging Pharma Leader.)

Rejuvenating Lives | 2023 Emerging Pharma Leader

Elaine Quilici is a contributing editor of 

Christi Shaw, this year’s Healthcare Businesswomen’s Association (HBA) Woman of the Year, stays true to her beliefs—and life mission—of helping others.

Unwavering Focus

Co-Founder and CEO John Oyler discusses the business decisions BeiGene makes to grow its pipeline and address drug pricing and access. 



A Vision of Affordability

Chronicling Davidek Herron’s career crossover from playing professional basketball to leading Roche’s digital transformation and scale-up efforts—and the team lessons learned along the way. 

The Pivot to Digital

Starting out with limited pharma business knowledge, how the lessons learned and realizations made helped to forge a destined—and globe-spanning—leadership path for Christophe Bourdon, where today, as CEO of LEO Pharma, he is tasked with steering the longtime company’s return to profitability.

Executive Profiles